NFKB1 and neoplasm: Zhou et al. (2005) demonstrated that NF-κB activation correlates with poor prognosis in TNBC patients, and silibinin-treated xenografts exhibit 50% smaller tumor volumes and 65% fewer lung metastases compared to controls [33].